Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis

Kelley, 2003, Gastric cancer epidemiology and risk factors, J Clin Epidemiol, 56, 1, 10.1016/S0895-4356(02)00534-6 Parkin, 1999, Global cancer statistics, CA Cancer J Clin, 49, 33, 10.3322/canjclin.49.1.33 Ikeguchi, 1994, Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer, Anticancer Res, 14, 2131 Gunderson, 1982, Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy, Int J Radiat Oncol Biol Phys, 8, 1, 10.1016/0360-3016(82)90377-7 Hamazoe, 1994, Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study, Cancer, 73, 2048, 10.1002/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q Ikeguchi, 1995, Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion, Eur J Surg, 161, 581 Koga, 1988, Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C, Cancer, 61, 232, 10.1002/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U Nakamura, 1992, Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy, Cancer, 70, 1030, 10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C Kuramoto, 2009, Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma, Ann Surg, 250, 242, 10.1097/SLA.0b013e3181b0c80e Yan, 2007, A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric Cancer, Ann Surg Oncol, 14, 2702, 10.1245/s10434-007-9487-4 Coccolini, 2014, Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials, EJSO, 40, 12, 10.1016/j.ejso.2013.10.019 Wagner, 2010, Chemotherapy for advanced gastric cancer, Cochrane Database Syst Rev, 17, CD004064 Van Cutsem, 2006, Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group, J Clin Oncol, 24, 4991, 10.1200/JCO.2006.06.8429 Cunningham, 2008, Capecitabine and oxaliplatin for advanced esophagogastric cancer, N Engl J Med, 358, 36, 10.1056/NEJMoa073149 Roth, 2007, Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research, J Clin Oncol, 25, 3217, 10.1200/JCO.2006.08.0135 Ross, 2002, Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer, J Clin Oncol, 20, 1996, 10.1200/JCO.2002.08.105 Baba, 2003, Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer, Gastric Cancer, 6, 45, 10.1007/s10120-003-0222-y Preusser, 1989, Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer, J Clin Oncol, 7, 1310, 10.1200/JCO.1989.7.9.1310 Al-Shammaa, 2008, Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, World J Gastroenterol, 14, 11, 10.3748/wjg.14.1159 Jacquet, 1996, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, 82, 359, 10.1007/978-1-4613-1247-5_23 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Slim, 2003, Methodological index for non-randomized studies (MINORS): development and validation of a new instrument, ANZ J Surg, 73, 712, 10.1046/j.1445-2197.2003.02748.x Demets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 6, 341, 10.1002/sim.4780060325 Hagiwara, 1992, Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer, Lancet, 339, 629, 10.1016/0140-6736(92)90792-2 Yonemura, 1996, Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination, Surgery, 119, 437, 10.1016/S0039-6060(96)80145-0 Glehen, 2004, Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer, Arch Surg, 139, 20, 10.1001/archsurg.139.1.20 Hall, 2004, Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer, J Gastrointest Surg, 8, 454, 10.1016/j.gassur.2003.12.014 Yonemura, 2005, Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion, Br J Surg, 92, 370, 10.1002/bjs.4695 Cheong, 2007, Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer, Ann Surg Oncol, 14, 61, 10.1245/s10434-006-9205-7 Scaringi, 2008, Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience, Eur J Surg Oncol, 34, 1246, 10.1016/j.ejso.2007.12.003 Glehen, 2010, Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients, Cancer, 116, 5608, 10.1002/cncr.25356 Yang, 2010, Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a Chinese center, J Surg Oncol, 101, 457, 10.1002/jso.21519 Yang, 2011, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial, Ann Surg Oncol, 18, 1575, 10.1245/s10434-011-1631-5 Yonemura, 2010, Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer, World J Gastrointest Oncol, 2, 85, 10.4251/wjgo.v2.i2.85 Montori, 2014, The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art, Int J Surg Oncol, 912 U1, 2014, Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial, J Surg Oncol, 110, 275, 10.1002/jso.23633 Cunningham, 2006, Perioperative chemotherapy versus 287 surgery alone for resectable gastroesophageal cancer, N Engl J Med, 355, 11, 10.1056/NEJMoa055531 Ychou, 2011, Perioperative chemoterapy compared with surgery 289 alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter 290 phase III Trial, J Clin Oncol, 29, 1715, 10.1200/JCO.2010.33.0597 Schumacher, 2010, Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954, J Clin Oncol, 28, 5210, 10.1200/JCO.2009.26.6114 Gill, 2011, Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity, J Surg Oncol, 104, 692, 10.1002/jso.22017 Roviello, 2013, Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale, Eur J Surg Oncol, 39, 1309, 10.1016/j.ejso.2013.10.010 Yamamura, 2007, Distribution of free cancer cells in the abdominal cavity suggests limitation of bursectomy as an essential component of radical surgery for gastric cancer, Gastric Cancer, 10, 4, 10.1007/s10120-006-0404-5 Yonemura, 2008, Treatment for potentially curable gastric cancer patients with intraperitoneal free cancer cells, Gastroenterol Surg, 31, 802 Yonemura, 2006, Neoadjuvant treatment of gastric cancer with peritoneal dissemination, EJSO, 32, 661, 10.1016/j.ejso.2006.03.007 Glehen, 2010, Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy, Ann Surg Oncol, 17, 2370, 10.1245/s10434-010-1039-7 Yonemura, 2009, Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery, J Surg Oncol, 100, 311, 10.1002/jso.21324 Yabusaki, 2003, Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer, Gan To Kagaku Ryoho, 30, 1933 Canbay, 2014, Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan, Ann Surg Oncol, 21, 1147, 10.1245/s10434-013-3443-2